Mounjaro®
Starting from £179.99/mo
Start journey Learn moreIf you have the flu and you're due your Wegovy injection, the decision is not straightforward. Flu brings vomiting, poor appetite and dehydration — all of which interact with semaglutide in ways that matter. The short answer: continuing your dose during a significant bout of flu carries real risks, and pausing is often the safer call until you recover. This is a clinical decision, though, not a blanket rule, and the right answer depends on how unwell you actually are, whether you can keep fluids down, and what your prescriber advises. If you're unsure whether Wegovy suits your situation at any stage, that conversation should always start with your clinical team.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
Wegovy slows gastric emptying and suppresses appetite as part of how it works. On a normal week, this is precisely the point. During flu, your stomach is already struggling. The nausea that comes with influenza (alongside a body temperature pushing upward, no appetite, and disrupted sleep) sits on top of a medicine that adds its own GI load. The result is that symptoms which would be unpleasant on their own can become seriously draining when semaglutide is in the picture.
Dehydration is the specific concern flagged in NHS guidance on semaglutide. If vomiting or diarrhoea means you cannot replace fluids fast enough, the kidneys take strain. This is not a theoretical risk. The NHS explicitly advises stopping your injection and seeking medical attention if you are severely dehydrated from illness while on a GLP-1 medicine. Severe, persistent stomach pain that spreads to your back is a separate red flag that should prompt urgent medical review, as the MHRA has highlighted in its safety communications on GLP-1 medicines.
Mild flu (a sore throat, a headache, feeling tired) is a different scenario from the full picture of influenza with fever and repeated vomiting. Your prescriber can help you draw that line if you are unsure where your symptoms fall. Contacting the nume support team is always an option if you need guidance between scheduled reviews.
This is where the SK3 framing matters most: you are making a real decision, and the factors are not all equal. Think through each honestly.
Can you keep fluids down? If the answer is no, or only barely, pausing your injection is the safer path. Semaglutide's gastric-slowing effect will not help a stomach that is already rejecting everything. Hydration comes first.
How severe are your GI symptoms right now? Mild queasiness is different from hours of vomiting. The former might not require any change at all. The latter does. Be honest about where you are on that spectrum before deciding anything.
Where are you in your titration schedule? Someone on the 0.25mg starting dose has far less circulating drug than someone established on 1.7mg or 2.4mg. The interaction between flu symptoms and the medicine is dose-dependent. People further along in treatment tend to feel the combined effect more acutely. Your Wegovy treatment overview can give you context on the dose schedule if you need a reminder.
What does your prescriber say? This question sits above all the others. A one-off missed injection (even two) will not undo weeks of treatment. The half-life of semaglutide means a short pause does not suddenly reset your progress. Missing a dose during illness, then resuming normally once you are recovered and hydrated, is far preferable to pressing through and landing in urgent care with severe dehydration.
Once you are genuinely better (eating normally, keeping fluids down, temperature back to baseline) you can usually pick up with your next scheduled injection. The NHS patient information for semaglutide advises that if you miss a dose and your next one is more than two days away, take the missed dose then; if your next scheduled injection is within two days, skip it and continue your normal weekly schedule. Never take two doses to catch up. For precise timing and your individual situation, the Patient Information Leaflet is the authoritative reference, and your prescriber is the right person to call if the timing does not fit neatly into either scenario.
Coming back from a flu-related pause is not the time to try moving up a dose level. Your system has been under stress. Give it a week at the dose you were on before any change is considered, and only move up under prescriber guidance, not independently. If you want a broader picture of how eligibility and suitability are assessed over time, the BMI and suitability page covers how the clinical picture is reviewed. Cost and continuity sometimes come into question after a treatment pause too; the Wegovy cost context page lays out what private treatment involves across a course of treatment.
One practical note: your injection arrives via tracked DPD in plain, unbranded packaging. If a delivery lands while you are too unwell to use it, a pen stored correctly in the fridge holds well, check the Patient Information Leaflet for the exact storage window, and contact your prescriber before using a pen whose storage you are uncertain about.
Some scenarios go beyond a prescriber chat and need urgent medical attention. Call 111 or your GP (or 999 if symptoms are severe) if you experience any of the following while on Wegovy during illness: signs of serious dehydration (no urination for hours, dark urine, dizziness on standing), severe stomach pain that reaches through to your back, signs of a serious allergic reaction (face or throat swelling, difficulty breathing), or high fever that is not responding to standard measures.
These are not meant to alarm. The NHS England guidance on weight-management injections is clear that the vast majority of people tolerate Wegovy well during minor illness, and the GI side effects from semaglutide do tend to ease over time. But flu is not minor illness for everyone, and treating your symptoms carefully, drinking fluids, and giving your body time to recover should come ahead of rigid adherence to a weekly injection schedule. You can also report any unexpected side effects via the MHRA's Yellow Card scheme, which remains open for both patients and carers.
If you are not yet on treatment and are wondering about whether you meet the BMI threshold for Wegovy, or have related questions such as whether a specific health condition affects suitability, those questions are best answered through a free consultation with a prescriber. There is no obligation, and a real clinician reviews every response the same day it arrives.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.